Overview

Eletriptan Pharmacokinetics In Korean Males

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this study is that Korean subjects have similar Pharmacokinetics (PK) characteristics to those seen in other populations.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Eletriptan